Description
COSPAIQ S 25+100 Tablet is a fixed-dose combination of Dapagliflozin and Linagliptin for type 2 diabetes management. This combination provides complementary mechanisms for enhanced glycemic control. COSPAIQ S 25+100 Tablet is available in tablet form for convenient oral administration. Use the product according to the instructions provided on the packaging or as advised by a healthcare professional. Please read the product label carefully and follow all recommended precautions and warnings before using this medicine. Important Note: This information is for general product purposes only and is not intended as medical advice. Always consult a healthcare professional before use.
Reviews
There are no reviews yet.